Effectiveness of single doses of Fenbendazole Hoe 881 against Ascaris, hookworm and Trichuris in man (1976)

Peer-Reviewed Study · Bruch K, Haas J · June 1976

Bruch K et al., 1976-06: Early controlled human trial of fenbendazole (Hoe 881) as an anthelmintic: single oral doses of 1.0-1.5 g reduced Ascaris and hookworm egg counts and 1.5 g worked against Trichuris, with efficacy comparable to pyrantel and tested against placebo.

In a comparative trial using Hoe 881 1-5 g, Pyrantel 10 mg/kg and placebo respectively Hoe 881 showed equal potency against hookworms and Acsaris as Pyrantel and good effectiveness against Trichuris.

Abstract

Bruch K et al., 1976-06: Early controlled human trial of fenbendazole (Hoe 881) as an anthelmintic: single oral doses of 1.0-1.5 g reduced Ascaris and hookworm egg counts and 1.5 g worked against Trichuris, with efficacy comparable to pyrantel and tested against placebo. Study type: comparative clinical trial with placebo arm (not randomised in the abstract's description), human subjects, country not stated in the abstract (Hoechst, Germany). Dose: 1.0 g and 1.5 g per person single oral dose; also two 500 mg doses 24 h apart; comparator pyrantel 10 mg/kg and placebo. Funder: not stated in the record (authors from Hoechst AG). Declared conflicts: none captured. Outcome: egg-count reduction, not cancer. Bearing basis: this is the origin of the human safety/dose literature the cancer protocols draw on, and it is a parasitology trial, not an oncology one. Study type: controlled study.